QCG
TXG icon

Quadrant Capital Group’s 10x Genomics TXG Stock Holding History

Quadrant Capital Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8K Hold
982
– – ﹤0.01% 1983
2025
Q4 		$16K Hold
982
– – ﹤0.01% 2071
2025
Q3 		$11.5K Buy
+982
New +$12.8K ﹤0.01% 2125
2025
Q2 		– Sell
-3,900
Closed -$34K – 2542
2025
Q1 		$34K Buy
3,900
+3,748
+2,466% +$47.2K ﹤0.01% 1855
2024
Q4 		$2.18K Sell
152
-102
-40% -$1.61K ﹤0.01% 2485
2024
Q3 		$5.74K Buy
254
+226
+807% +$4.67K ﹤0.01% 2291
2024
Q2 		$545 Sell
28
-67
-71% -$1.75K ﹤0.01% 2612
2024
Q1 		$3.57K Sell
95
-55
-37% -$2.42K ﹤0.01% 2392
2023
Q4 		$8.39K Buy
150
+1
+0.7% +$44 ﹤0.01% 2132
2023
Q3 		$6.15K Hold
149
– – ﹤0.01% 2120
2023
Q2 		$8.32K Hold
149
– – ﹤0.01% 2071
2023
Q1 		$8.31K Sell
149
-82
-35% -$3.83K ﹤0.01% 2101
2022
Q4 		$8.42K Buy
231
+117
+103% +$3.83K ﹤0.01% 2037
2022
Q3 		$3K Buy
114
+66
+138% +$2.51K ﹤0.01% 2302
2022
Q2 		$2K Sell
48
-51
-52% -$2.65K ﹤0.01% 2284
2022
Q1 		$8K Buy
99
+1
+1% +$87 ﹤0.01% 1760
2021
Q4 		$15K Buy
98
+36
+58% +$5.51K ﹤0.01% 1454
2021
Q3 		$9K Buy
62
+4
+7% +$687 ﹤0.01% 1662
2021
Q2 		$11K Sell
58
-43
-43% -$7.78K ﹤0.01% 1524
2021
Q1 		$18K Buy
101
+50
+98% +$8.63K ﹤0.01% 1238
2020
Q4 		$7K Buy
+51
New +$7.4K ﹤0.01% 1595
2020
Q3 		– Sell
-151
Closed -$13K – 2311
2020
Q2 		$13K Buy
+151
New +$11.8K ﹤0.01% 1228

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's TXG Position: Q1 2026 in Review

Quadrant Capital Group held its 10x Genomics (TXG) position steady in Q1 2026 at 982 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Quadrant Capital Group first reported a position in TXG in Q2 2020 and has held it in 22 quarters since. The position peaked at $34K in Q1 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Quadrant Capital Group held 982 shares of 10x Genomics worth $20.8K as of Q1 2026.
  • Quadrant Capital Group left its 10x Genomics share count unchanged in Q1 2026.
  • 10x Genomics made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1983 holding.
  • Quadrant Capital Group first reported a position in 10x Genomics in Q2 2020 and has held it in 22 quarters since.
  • Quadrant Capital Group's 10x Genomics position peaked at $34K in Q1 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.